Liver Transplantation Versus ALPPS for Colorectal Liver Metastases
Matteo Serenari(Azienda USL di Bologna), Alessandro Ferrero, Luca Aldrighetti(Vita-Salute San Raffaele University), Jacopo Lanari(University of Padua), Fabrizio Di Benedetto(University of Modena and Reggio Emilia), Umberto Cillo(University of Padua), Matteo Cescon(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Marco Massani(AULSS 2 Marca Trevigiana), D. Pinelli(Ospedale Papa Giovanni XXIII), Svein Dueland(Oslo University Hospital), Vincenzo Mazzaferro(Fondazione IRCCS Istituto Nazionale dei Tumori), Elio Jovine(Azienda USL di Bologna), Pål‐Dag Line(Oslo University Hospital), Marco Vivarelli, Gian Luca Grazi(Azienda Ospedaliero-Universitaria Careggi), Giuseppe Maria Ettorre(IRCCS San Camillo Hospital)
Cited by 2
Related Papers
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
|New England Journal of Medicine|1996|7.1k
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
|New England Journal of Medicine|2008|1.3k
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
|The Lancet Oncology|2015|1.1k
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
|Journal of Hepatology|2012|821